Cambridge Antibody Technology Group Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cambridge Antibody Technology Group

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: nigel bates	3/21/2005 12:22:21 PM
	of 625

Cambridge Antibody Technology Legal Action With Abbott: Abbott Granted Permission to Appeal Monday March 21, 12:12 pm ET CAMBRIDGE, England, March 21 /PRNewswire-FirstCall/ -- Cambridge Antibody Technology (LSE: CAT - News; Nasdaq: CATG - News) reports the decision by the Rt Hon Lord Justice Jacob, in the Court of Appeal, Civil Division, to grant Abbott permission to appeal Mr Justice Laddie's judgment in favour of CAT of 20 December 2004. In the Order from the Court of Appeal, the reasons for the decision are stated as follows: "The points raised in [Abbott's] notice of appeal (there is no separate skeleton argument) appear, just, to raise a real prospect of success and the commercial importance of the agreements is sufficient in the circumstances to provide a compelling reason for an appeal." The Civil Procedure Rules (CPR) that govern court procedures, state that "Permission to appeal will only be given where - (a) the Court considers that the appeal would have a real prospect of success; or (b) there is some other compelling reason why the appeal should be heard."...

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next